Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
187.21B | 189.19B | 208.35B | 241.39B | 157.74B | 105.94B | Gross Profit |
28.89B | 30.24B | 64.06B | 55.10B | 22.86B | 10.18B | EBIT |
15.72B | 12.85B | 46.98B | 44.76B | 15.09B | -346.00M | EBITDA |
26.99B | 27.98B | 43.50B | 59.47B | 32.55B | 14.54B | Net Income Common Stockholders |
-1.20B | 381.00M | 15.24B | -1.36B | 7.57B | -20.73B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
34.05B | 34.52B | 28.59B | 29.77B | 30.96B | 29.53B | Total Assets |
281.40B | 282.23B | 280.29B | 288.12B | 287.27B | 267.65B | Total Debt |
71.13B | 71.55B | 63.08B | 55.49B | 69.79B | 81.93B | Net Debt |
37.36B | 37.19B | 35.33B | 26.30B | 39.11B | 52.73B | Total Liabilities |
203.44B | 203.91B | 194.80B | 205.13B | 196.83B | 182.09B | Stockholders Equity |
58.22B | 59.25B | 70.28B | 67.55B | 75.46B | 71.25B |
Cash Flow | Free Cash Flow | ||||
10.19B | 12.00B | 17.75B | 28.86B | 12.72B | -144.00M | Operating Cash Flow |
25.12B | 27.30B | 32.04B | 40.93B | 23.61B | 12.16B | Investing Cash Flow |
-12.66B | -13.25B | -14.87B | -13.71B | -5.69B | -7.86B | Financing Cash Flow |
-9.99B | -7.30B | -13.36B | -28.02B | -18.08B | 3.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | £1.61B | 10.89 | 17.50% | 10.44% | -9.80% | -1.98% | |
78 Outperform | £2.40B | 14.11 | 5.54% | 11.65% | -16.96% | -34.52% | |
77 Outperform | £146.66B | 14.47 | 7.41% | 4.35% | -4.09% | -20.79% | |
77 Outperform | £1.31B | 9.65 | 9.56% | 5.04% | 89.44% | 540.95% | |
68 Neutral | £3.18B | 21.62 | -2.87% | 10.66% | 29.33% | ― | |
61 Neutral | £55.82B | 183.44 | -1.85% | 6.86% | -9.08% | -113.54% | |
57 Neutral | $7.14B | 3.09 | -4.49% | 5.67% | 0.82% | -49.15% |